U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C56H70N9O23S.Na
Molecular Weight 1292.256
Optical Activity UNSPECIFIED
Defined Stereocenters 14 / 15
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of (3S,4S)-(4R)-4,5-Dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-L-prolinamide sodium

SMILES

[Na+].CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N4C(O)[C@H](O)C[C@H]4C(=O)N[C@@H]([C@@H](C)O)C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H]([C@H](O)[C@@H](O)C6=CC=C(O)C(OS([O-])(=O)=O)=C6)C(=O)N[C@@H]([C@H](O)CC(N)=O)C(=O)N7C[C@H](C)[C@H](O)[C@H]7C(N)=O

InChI

InChIKey=DBNWVUGZEUASHB-ZLNXTIBKSA-M
InChI=1S/C56H71N9O23S.Na/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-20-33(62-87-39)27-7-9-29(10-8-27)53(79)65-35(21-38(70)54(65)80)51(77)59-42(26(3)66)55(81)63-24-31(67)19-34(63)50(76)61-44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)52(78)60-43(37(69)22-41(57)71)56(82)64-23-25(2)46(72)45(64)49(58)75;/h7-16,18,20,25-26,31,34-35,37-38,42-48,54,66-70,72-74,80H,4-6,17,19,21-24H2,1-3H3,(H2,57,71)(H2,58,75)(H,59,77)(H,60,78)(H,61,76)(H,83,84,85);/q;+1/p-1/t25-,26+,31+,34-,35-,37+,38+,42-,43-,44-,45-,46-,47-,48-,54?;/m0./s1

HIDE SMILES / InChI

Approval Year

Name Type Language
(3S,4S)-(4R)-4,5-Dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-L-prolinamide sodium
Systematic Name English
Micafungin open ring impurity
Preferred Name English
Micafungin open-ring analog sodium salt
Common Name English
Sodium [5-[(1S,2S,3S)-4-[[(2S,3R)-5-amino-1-[(2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl]-3-hydroxy-1,5-dioxopentan-2-yl]amino]-3-[[(2S,4R)-1-[(2S,3R)-2-[[(2S,4R)-4,5-dihydroxy-1-[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]pyrrolidine-2-
Systematic Name English
L-Prolinamide, (4R)-4,5-dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-, sodium salt, (3S
Systematic Name English
L-Prolinamide, (4R)-4,5-dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-, sodium salt (1:1
Systematic Name English
Code System Code Type Description
CAS
539823-82-0
Created by admin on Wed Apr 02 20:19:24 GMT 2025 , Edited by admin on Wed Apr 02 20:19:24 GMT 2025
PRIMARY
FDA UNII
9C62ZSN8N2
Created by admin on Wed Apr 02 20:19:24 GMT 2025 , Edited by admin on Wed Apr 02 20:19:24 GMT 2025
PRIMARY
PUBCHEM
171380930
Created by admin on Wed Apr 02 20:19:24 GMT 2025 , Edited by admin on Wed Apr 02 20:19:24 GMT 2025
PRIMARY